Oncotarget

Corrections:

Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting

PDF  |  How to cite

Oncotarget. 2018; 9:26977-26977. https://doi.org/10.18632/oncotarget.25604

Metrics: PDF 1280 views  |   ?  

Ji-Young Kim1,*, Ji-Hae Han1,*, Geon Park2, Young-Woo Seo3, Cheol-Won Yun4, Byung-Chul Lee5, Jeehyeon Bae6, Ae Ran Moon1,* and Tae-Hyoung Kim1,*

1Department of Biochemistry, Chosun University School of Medicine, Dong-Gu, Gwang-Ju, Korea
2Department of Laboratory Medicine, Chosun University School of Medicine, Dong-Gu, Gwang-Ju, Korea
3Korea Basic Science Institute Gwang-Ju Center, Chonnam National University, Buk-Gu, Gwang-Ju, Korea
4School of Life Science and Biotechnology, Korea University, Seoul, Korea
5Geno ux. Co., Ltd., Sejong City, Korea
6School of Pharmacy, Chung-Ang University, Dongjak-Gu, Seoul, Korea
*These authors equally contributed to this work

Published: June 01, 2018

This article has been corrected: The correct Grant Support information is given below:

GRANT SUPPORT

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant no. 2010-0009201 and NRF-2013R1A1A2058254 to TH Kim), by the Ministry of Science, ICT, and Future Planning (NRF-2014R1A2A1A11050442 to TH Kim), and by the National R&D Program for Cancer Control funded by the Ministry of Health and Welfare of the Korean government (Grant no. HI14C2025 to TH Kim).

Original article: Oncotarget. 2016; 7:32449-32461. DOI: https://doi.org/10.18632/oncotarget.8719.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25604